Concepedia

Castilho Vitor Quirino dos Santos

CV

Statistics

Publications

5

Citations

814

H-Index

5

Active since

2021

Affiliations

Impact(Current)

Pontifícia Universidade Católica de Minas Gerais

Universidade Federal de Ouro Preto

McMaster University

Universidade Estadual de Montes Claros

Castilho Vitor Quirino dos Santos is an author at Impact specializing in pharmacy, pharmacotherapy, and infectious disease pharmacotherapy.

Publications per year

2021–2023

5

Publications

5

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial

Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva et al. · The Lancet Global Health · 2021 · 400 citations · Full text

, , +10

Early Treatment with Pegylated Interferon Lambda for Covid-19

Gilmar Reis, Eduardo A.S. Moreira Silva, Daniela C. Medeiros Silva et al. · New England Journal of Medicine · 2023 · 174 citations · Full text

, , +12

Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · JAMA Network Open · 2021 · 141 citations · Full text

, , +12

RETRACTED: Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · The Lancet Regional Health - Americas · 2021 · 63 citations · Full text

, , +13

Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · Annals of Internal Medicine · 2023 · 36 citations · Full text

, , +17

1–5 of 5